Skip to main content

Table 2 ICU characteristics of the 501 patients included in the SENIOREA study

From: Determinants of hospital and one-year mortality among older patients admitted to intensive care units: results from the multicentric SENIOREA cohort

 

Number of patients with data available

Patients included (n = 501)

Location of the patient before ICU admission

501

 

 Acute facility care

 

290 (58%)

 Home

 

172 (34%)

 Chronic facility care

 

11 (2%)

 Supervised residence setting

 

8 (3%)

 Other

 

20 (4%)

Primary ICU diagnosis

498

 

 Septic shock

 

78 (15.7%)

 Non-septic shock

 

22 (4.4%)

 Resuscitated cardiac arrest

 

52 (10.4%)

 Acute on chronic respiratory failure

 

64 (12.9%)

 Acute respiratory failure

 

149 (29.9%)

 Acute kidney injury and metabolic disorders

 

11 (2.2%)

 Neurological disorder

 

51 (10.2%)

 Post-surgery

 

26 (5.2%)

 Drug overdose

 

5 (1%)

 Trauma

 

7 (1.4%)

 Other

 

33 (6.6%)

Admission SOFA, m ± sd

501

7.0 ± 3.7

Admission SAPSII, m ± sd

501

54 ± 17

Type of mechanical ventilation, n (%)

489

 

 Invasive only

 

290 (59.3%)

 Non-invasive only

 

98 (20.0%)

 Combined

 

101 (20.7%)

Total length of mechanical ventilation (days), m ± sd

463

7.5 ± 10.0

 Med (IQR)

 

4 (2–10)

Renal replacement therapy requirement

498

70 (14.1%)

Total length of renal replacement therapy, m ± sd

70

7.6 ± 9.3

 Med (IQR)

 

4 (1–11)

Vasopressor requirement

497

252 (50.7%)

Total length of vasopressor infusion (days), m ± sd

251

4.4 ± 6.2

 Med (IQR)

 

2 (1–5)

ICU length of stay (days), m ± sd

499

10.5 ± 13.8

 Med (IQR)

 

2 (1–5)

Hospital length of stay (days), m ± sd

499

20.2 ± 23.3

 Med (IQR)

 

14 (7–26)

ICU mortality

499

108 (21.6%)

Hospital mortality

499

130 (26.0%)

Limitation of life sustaining therapies, n (%)

447

135 (30.2%)

  1. Data are n (%), mean (m) ± standard deviation (sd) or median (med) with interquartile range (IQR). ICU, intensive care unit, SAPS, Simplified Acute Physiology Score, SOFA, Sequential Organ Failure Assessment